Applied Therapeutics Stock Short Ratio
| APLT Stock | USD 1.69 0.06 3.43% |
Applied Therapeutics fundamentals help investors to digest information that contributes to Applied Therapeutics' financial success or failures. It also enables traders to predict the movement of Applied Stock. The fundamental analysis module provides a way to measure Applied Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Applied Therapeutics stock.
Applied | Short Ratio |
Applied Therapeutics Company Short Ratio Analysis
Applied Therapeutics' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Applied Therapeutics Short Ratio | 7.70 X |
Most of Applied Therapeutics' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Applied Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Applied Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Applied Therapeutics is extremely important. It helps to project a fair market value of Applied Stock properly, considering its historical fundamentals such as Short Ratio. Since Applied Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Applied Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Applied Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Applied Therapeutics has a Short Ratio of 7.7 times. This is 97.44% higher than that of the Biotechnology sector and 3.91% higher than that of the Health Care industry. The short ratio for all United States stocks is 92.5% lower than that of the firm.
Applied Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Applied Therapeutics' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Applied Therapeutics could also be used in its relative valuation, which is a method of valuing Applied Therapeutics by comparing valuation metrics of similar companies.Applied Therapeutics is currently under evaluation in short ratio category among its peers.
Applied Therapeutics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Applied Therapeutics from analyzing Applied Therapeutics' financial statements. These drivers represent accounts that assess Applied Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Applied Therapeutics' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 350.0M | 483.5M | 229.1M | 28.7M | 282.2M | 176.7M | |
| Enterprise Value | 333.2M | 427.8M | 176.5M | 13.0M | 233.1M | 152.4M |
Applied Therapeutics Institutional Holders
Institutional Holdings refers to the ownership stake in Applied Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Applied Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Applied Therapeutics' value.| Shares | Simplify Asset Management Inc. | 2024-09-30 | 2.8 M | Tang Capital Management Llc | 2024-09-30 | 2.7 M | Deutsche Bank Ag | 2024-06-30 | 2.3 M | Geode Capital Management, Llc | 2024-09-30 | 2.1 M | Rock Springs Capital Management Lp | 2024-09-30 | 1.7 M | Stempoint Capital Lp | 2024-09-30 | 1.6 M | Opaleye Management Inc | 2024-09-30 | 1.3 M | Vestal Point Capital Lp | 2024-09-30 | 1.1 M | T. Rowe Price Associates, Inc. | 2024-09-30 | 1 M | Hhg Plc | 2024-09-30 | 10.5 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 9.9 M |
Applied Fundamentals
| Return On Equity | -4.73 | ||||
| Return On Asset | -0.76 | ||||
| Operating Margin | (243.80) % | ||||
| Current Valuation | 106.73 M | ||||
| Shares Outstanding | 116.36 M | ||||
| Shares Owned By Insiders | 5.23 % | ||||
| Shares Owned By Institutions | 94.77 % | ||||
| Number Of Shares Shorted | 13.56 M | ||||
| Price To Earning | (7.46) X | ||||
| Price To Book | 34.56 X | ||||
| Price To Sales | 54.68 X | ||||
| Revenue | 9.99 M | ||||
| EBITDA | (64.53 M) | ||||
| Net Income | (119.76 M) | ||||
| Cash And Equivalents | 67.72 M | ||||
| Cash Per Share | 1.41 X | ||||
| Total Debt | 777 K | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 1.49 X | ||||
| Book Value Per Share | 0.05 X | ||||
| Cash Flow From Operations | (55.17 M) | ||||
| Short Ratio | 7.70 X | ||||
| Earnings Per Share | (1.42) X | ||||
| Target Price | 6.67 | ||||
| Number Of Employees | 37 | ||||
| Beta | 2.02 | ||||
| Market Capitalization | 196.64 M | ||||
| Total Asset | 54.83 M | ||||
| Retained Earnings | (468.59 M) | ||||
| Working Capital | (16.8 M) | ||||
| Current Asset | 37.74 M | ||||
| Current Liabilities | 11.19 M | ||||
| Net Asset | 54.83 M |
About Applied Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Applied Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Applied Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Applied Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.